These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 8132768

  • 1. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
    Hollak CE, van Weely S, van Oers MH, Aerts JM.
    J Clin Invest; 1994 Mar; 93(3):1288-92. PubMed ID: 8132768
    [Abstract] [Full Text] [Related]

  • 2. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
    Dodelson de Kremer R, Paschini de Capra A, Angaroni CJ, Giner de Ayala A.
    Medicina (B Aires); 1997 Mar; 57(6):677-84. PubMed ID: 9674188
    [Abstract] [Full Text] [Related]

  • 3. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity].
    Wang Y, Zhang HW, Ye J, Qiu WJ, Han LS, Gu XF.
    Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614
    [Abstract] [Full Text] [Related]

  • 4. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers).
    Giraldo P, Cenarro A, Alfonso P, Pérez-Calvo JI, Rubio-Félix D, Giralt M, Pocoví M.
    Haematologica; 2001 Sep; 86(9):977-84. PubMed ID: 11532627
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.
    Boomsma JM, van Dussen L, Wiersma MG, Groener JE, Aerts JM, Maas M, Hollak CE.
    Blood Cells Mol Dis; 2010 Mar 15; 44(3):181-7. PubMed ID: 20074983
    [Abstract] [Full Text] [Related]

  • 6. Plasma chitotriosidase activity in patients with beta-thalassemia.
    Barone R, Di Gregorio F, Romeo MA, Schilirò G, Pavone L.
    Blood Cells Mol Dis; 1999 Feb 15; 25(1):1-8. PubMed ID: 10349508
    [Abstract] [Full Text] [Related]

  • 7. Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease.
    Wajner A, Michelin K, Burin MG, Pires RF, Pereira ML, Giugliani R, Coelho JC.
    Clin Biochem; 2007 Mar 15; 40(5-6):365-9. PubMed ID: 17291472
    [Abstract] [Full Text] [Related]

  • 8. Chitotriosidase determination in plasma and in dried blood spots: a comparison using two different substrates in a microplate assay.
    Rodrigues MD, de Oliveira AC, Müller KB, Martins AM, D'Almeida V.
    Clin Chim Acta; 2009 Aug 15; 406(1-2):86-8. PubMed ID: 19501579
    [Abstract] [Full Text] [Related]

  • 9. Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring.
    Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ.
    Hum Mutat; 2007 Sep 15; 28(9):866-73. PubMed ID: 17464953
    [Abstract] [Full Text] [Related]

  • 10. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy.
    Vedder AC, Cox-Brinkman J, Hollak CE, Linthorst GE, Groener JE, Helmond MT, Scheij S, Aerts JM.
    Mol Genet Metab; 2006 Nov 15; 89(3):239-44. PubMed ID: 16765076
    [Abstract] [Full Text] [Related]

  • 11. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases.
    Wajner A, Michelin K, Burin MG, Pires RF, Pereira ML, Giugliani R, Coelho JC.
    Clin Biochem; 2004 Oct 15; 37(10):893-7. PubMed ID: 15369720
    [Abstract] [Full Text] [Related]

  • 12. Plasma chitotriosidase activity in patients with beta-thalassemia.
    Altarescu G, Rudensky B, Abrahamov A, Goldfarb A, Rund D, Zimran A, Elstein D.
    Am J Hematol; 2002 Sep 15; 71(1):7-10. PubMed ID: 12221666
    [Abstract] [Full Text] [Related]

  • 13. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
    Dimitriou E, Verhoek M, Altun S, Karabatsos F, Moraitou M, Youssef J, Boot R, Sarafidou J, Karagiorga M, Aerts H, Michelakakis H.
    Blood Cells Mol Dis; 2005 Sep 15; 35(3):328-31. PubMed ID: 16137900
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of Gaucher patients with a novel chitotriosidase assay.
    Schoonhoven A, Rudensky B, Elstein D, Zimran A, Hollak CE, Groener JE, Aerts JM.
    Clin Chim Acta; 2007 Jun 15; 381(2):136-9. PubMed ID: 17408605
    [Abstract] [Full Text] [Related]

  • 15. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.
    Boot RG, Hollak CE, Verhoek M, Alberts C, Jonkers RE, Aerts JM.
    Clin Chim Acta; 2010 Jan 15; 411(1-2):31-6. PubMed ID: 19808030
    [Abstract] [Full Text] [Related]

  • 16. Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.
    Irún P, Alfonso P, Aznarez S, Giraldo P, Pocovi M.
    Clin Biochem; 2013 Dec 15; 46(18):1804-7. PubMed ID: 24060732
    [Abstract] [Full Text] [Related]

  • 17. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
    Pastores GM, Barnett NL, Kolodny EH.
    Clin Ther; 2005 Aug 15; 27(8):1215-27. PubMed ID: 16199246
    [Abstract] [Full Text] [Related]

  • 18. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T, Deegan PB, Yang R, Pavlova E, Stirnemann J, Labarère J, Zimran A, Mistry PK, Berger M.
    Syst Rev; 2017 Apr 20; 6(1):87. PubMed ID: 28427477
    [Abstract] [Full Text] [Related]

  • 19. Plasmalogen levels in Gaucher disease.
    Moraitou M, Dimitriou E, Zafeiriou D, Reppa C, Marinakis T, Sarafidou J, Michelakakis H.
    Blood Cells Mol Dis; 2008 Apr 20; 41(2):196-9. PubMed ID: 18501647
    [Abstract] [Full Text] [Related]

  • 20. Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention.
    Meikle PJ, Whitfield PD, Rozaklis T, Blacklock D, Duplock S, Elstein D, Zimran A, Mengel E, Cannell P, Hopwood JJ, Fuller M.
    Blood Cells Mol Dis; 2008 Apr 20; 40(3):420-7. PubMed ID: 18054258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.